Tianjin Third central Hospital
π¨π³China
Clinical Trials
7
Active:0
Completed:1
Trial Phases
2 Phases
Phase 4:1
Not Applicable:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
5 (83.3%)Phase 4
1 (16.7%)A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC.
Recruiting
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Tianjin Third Central Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06134973
- Locations
- π¨π³
ηθ³, Tianjin, Tianjin, China
Study of Microwave Spherical Ablation and Traditional Microwave Ablation in Single Hepatocellular Carcinoma β€5cm
Not Applicable
Recruiting
- Conditions
- Microwave AblationMicrowave Spherical AblationPrognosisHepatocellular Cancer
- First Posted Date
- 2022-05-04
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- Tianjin Third Central Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05361538
- Locations
- π¨π³
Tianjin Third Central Hospital, Tianjin, Tianjin, China
Diagnosis of Nodules β€2 cm Based on US and CEUS Compared With Current Clinical Procedure
Not Applicable
Recruiting
- Conditions
- Liver CirrhosisLiver Cancer
- First Posted Date
- 2022-05-04
- Last Posted Date
- 2022-12-13
- Lead Sponsor
- Tianjin Third Central Hospital
- Target Recruit Count
- 6730
- Registration Number
- NCT05360420
- Locations
- π¨π³
Tianjin Third Central Hospital, Tianjin, Tianjin, China
Fusion Imaging Contrast-enhanced Ultrasound LI-RADS
Not Applicable
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- Tianjin Third Central Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT04955119
- Locations
- π¨π³
Tianjin Third Central Hospital, Tianjin, Tianjin, China
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC
Not Applicable
Completed
- Conditions
- Hepatocellular CancerDiagnoses DiseaseLiver Cirrhoses
- First Posted Date
- 2019-12-26
- Last Posted Date
- 2022-03-07
- Lead Sponsor
- Tianjin Third Central Hospital
- Target Recruit Count
- 115
- Registration Number
- NCT04212286
- Locations
- π¨π³
Tianjin Third Central Hospital, Tianjin, Tianjin, China
- Prev
- 1
- 2
- Next
News
No news found